Beta Bionics, Inc. (BBNX) stock
BBNXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 11/304% below fair value
$14.33−0.39 (-2.65%)
Close on Nov 18, 2026Market cap $779.08MP/E –Yield –
Beta Bionics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Beta Bionics's revenue for the twelve months ending Sep 30, 2026 was $127.27M, up 43.7% year over year. For fiscal 2025 it was $100.25M, up 53.9% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $100.25M | +53.9% |
| FY2024 | Dec 31, 2024 | $65.12M | +442.9% |
| FY2023 | Dec 31, 2023 | $12.00M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $35.51M | +30.3% |
| Q2 FY2026 | Jun 30, 2026 | $32.01M | +37.8% |
| Q1 FY2026 | Mar 31, 2026 | $27.63M | +56.6% |
| Q4 FY2025 | Dec 31, 2025 | $32.12M | +57.1% |
| Q3 FY2025 | Sep 30, 2025 | $27.25M | +63.1% |
| Q2 FY2025 | Jun 30, 2025 | $23.24M | +54.4% |
| Q1 FY2025 | Mar 31, 2025 | $17.64M | +36.4% |
| Q4 FY2024 | Dec 31, 2024 | $20.44M | – |
| Q3 FY2024 | Sep 30, 2024 | $16.71M | – |
| Q2 FY2024 | Jun 30, 2024 | $15.05M | – |
| Q1 FY2024 | Mar 31, 2024 | $12.93M | – |
See a number that looks wrong?